Moreover, CS-GRP78 is a host factor that plays an essential role in allowing pathogens, such as viruses, in entering and infect cells, so inhibition of GRP78 may also provide potential therapeutic benefits when treating certain bacterial and viral infections [17, 112]. This evidence concerns the gene HSPA5 and viral infectious disease.